Lilly Cuts Insulin Prices, Capping Monthly Out of Pocket Costs For Many
Hw=ealth -- Eli Lilly and Company's (NYSE: LLY) made an announcemetn price reductions for most frequently
prescribed insulins will be reduced by 70%, and the Insulin Value Program, which limits patients' out-of-pocket